Concepedia

Dzhamal Abdurakhmanov

DA

Statistics

Publications

8

Citations

195

H-Index

8

Active since

2013

Affiliations

Sechenov University(Current)

Gilead Sciences (United States)

Lomonosov Moscow State University

Regional Center for Prevention and Control of AIDS and Infectious Diseases

Dzhamal Abdurakhmanov is an author at Sechenov University specializing in hepatology, autoimmune liver disease, and viral hepatitis.

ORCID

Top concepts

Publications per year

2013–2024

8

Publications

8

Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C

M. Colombo, Inmaculada Fernández, Dzhamal Abdurakhmanov et al. · Gut · 2013 · 46 citations · Full text

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic <scp>HCV</scp> genotype 1 infection (<scp>ESSENTIAL II</scp>)

Stefan Zeuzem, Robert Flisiak, John M. Vierling et al. · Alimentary Pharmacology & Therapeutics · 2015 · 41 citations · Full text

Direct‐acting antiviral agents for hepatitis C virus‐mixed cryoglobulinaemia: dissociated virological and haematological responses

Gabriele Pozzato, Cesare Mazzaro, Marina Artemova et al. · British Journal of Haematology · 2020 · 29 citations · Full text

Eight‐year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials

Young‐Suk Lim, Henry Lik‐Yuen Chan, Kosh Agarwal et al. · Alimentary Pharmacology & Therapeutics · 2024 · 19 citations · Full text

Daclatasvir<i>vs</i>telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1

Ira M. Jacobson, Stefan Zeuzem, Robert Flisiak et al. · World Journal of Gastroenterology · 2016 · 18 citations · Full text

1–5 of 8